Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo-Tied Convergence Pain-Drug Maker Considers IPO
Bloomberg
Monday, June 16, 2014 - 10:46am
tags:
GSK, CNV1014802, trigeminal neuralgia, Convergence Pharmaceuticals
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Monday, June 16, 2014 - 10:17am
tags:
Biogen, AbbVie, daclizumab, MS, multiple sclerosis
Ligand Promacta data should support approval, says Roth Capital
Yahoo/The Fly on the Wall
Monday, June 16, 2014 - 10:04am
tags:
Ligand Pharmaceuticals, GSK, Promacta, thrombocytopenia
Bluebird Stock Rockets On Gene Therapy Results
Forbes
Monday, June 16, 2014 - 10:02am
tags:
Bluebird Bio, beta-thalassemia
Agios Pharmaceuticals announces AG-221 orphan drug designation
Yahoo/The Fly on the Wall
Monday, June 16, 2014 - 9:58am
tags:
Agios Pharmaceuticals, AG-221, acute myelogenous leukemia, leukemia
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties
Yahoo/Baystreet
Monday, June 16, 2014 - 9:55am
tags:
Theralase
The Sirens of Ziopharm
Seeking Alpha
Monday, June 16, 2014 - 7:37am
tags:
sarcoma, oncology, Ziopharm
Medtronic to buy Covidien for $42.9 billion, rebase in Ireland
Reuters
Monday, June 16, 2014 - 7:30am
tags:
M&A, devices, Ireland, Covidien, Medtronic
Better Marijuana Stock: GW Pharma vs Insys
Motley Fool
Monday, June 16, 2014 - 7:23am
tags:
Medical Marijuana, GW Pharma, Insys
Is Gene Therapy Medicine's Next Big Thing?
Motley Fool
Sunday, June 15, 2014 - 7:04pm
tags:
gene therapy, Bluebird Bio
Will These 3 Products Revolutionize Diabetes Treatment?
Motley Fool
Sunday, June 15, 2014 - 6:58pm
tags:
diabetes, MannKind, Afrezza, Novo Nordisk, Apple
GSK spin-off gears up for possible listing
FT.com
Sunday, June 15, 2014 - 6:51pm
tags:
GSK, Convergence Pharmaceuticals, trigeminal neuralgia
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sunday, June 15, 2014 - 6:31pm
tags:
InterMune, Esbriet, Actelion, Gilead Sciences
Novo Nordisk diabetes drug appears effective for weight loss -study
Yahoo/Reuters
Sunday, June 15, 2014 - 10:44am
tags:
Novo Nordisk, obesity, diabetes, Victoza
Medtronic Said to Be Looking to Cut Taxes With $40 Billion Covidien Deal
Yahoo/Bloomberg
Sunday, June 15, 2014 - 10:42am
tags:
M&A, Medtronic, Covidien, devices
Is Pfizer At A Saturation Point?
Seeking Alpha
Sunday, June 15, 2014 - 10:35am
tags:
Pfizer
New rivals to top diabetes drug Lantus show promise in studies
Yahoo/Reuters
Sunday, June 15, 2014 - 10:33am
tags:
diabetes, Lantus, insulin, Sanofi, Toujeo, Eli Lilly
Sanofi and Medtronic team up on diabetes drug-device combination
Yahoo/Reuters
Sunday, June 15, 2014 - 10:06am
tags:
Medtronic, Sanofi, diabetes, devices
Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement
Pipeline Review
Saturday, June 14, 2014 - 9:51am
tags:
Takeda, Affymax, Omontys, anemia
Bayer faces law suits in United States over Xarelto -paper
Yahoo/Reuters
Saturday, June 14, 2014 - 9:34am
tags:
Bayer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.